MEDGX | PAEMX | MEDGX / PAEMX | |
Total Expense Ratio | 0.81 | 1.67 | 49% |
Annual Report Gross Expense Ratio | 0.82 | 1.67 | 49% |
Fund Existence | 17 years | 28 years | - |
Gain YTD | 5.958 | 7.731 | 77% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.4B | 2.13B | 347% |
Annual Yield % from dividends | 5.87 | 6.84 | 86% |
Returns for 1 year | 8.08 | 10.25 | 79% |
Returns for 3 years | 27.17 | 28.94 | 94% |
Returns for 5 years | 10.62 | 10.68 | 99% |
Returns for 10 years | 43.35 | 45.30 | 96% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GLNMX | 24.69 | -0.03 | -0.12% |
MFS Global New Discovery R4 | |||
VADGX | 29.64 | -0.16 | -0.54% |
Vanguard Advice Select Dividend Gr Admrl | |||
DINIX | 22.31 | -0.13 | -0.58% |
BNY Mellon International Stock Index I | |||
FLPKX | 43.16 | -0.58 | -1.33% |
Fidelity Low-Priced Stock K | |||
FTWRX | 18.38 | -0.34 | -1.82% |
Templeton World R6 |